Intrahepatic Cholestasis References

REFERENCES

European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol. 2009 Aug;51(2):237-267. doi: 10.1016/j.jhep.2009.04.009. PMID: 19501929
Ahmed KT, Almashhrawi AA, Rahman RN, et al. Liver diseases in pregnancy: diseases unique to pregnancy. World J Gastroenterol. 2013 Nov;19(43):7639-7646. http://www.ncbi.nlm.nih.gov. Accessed 20 Jan 2015. PMID: PMC3837262
Chapman R, Fevery J, Kalloo A, et al. American Association for the Study of Liver Diseases (AASLD) practice guidelines: diagnosis and management of primary sclerosing cholangitis. Hepatology. 2010 Feb;1(2):660-678. doi: 10.1002/hep.23294. Accessed 12 Jan 2015. PMID: 20101749
deLemos AS, Pratt DS. Immunoglobulin G4-associated cholangitis: the next great masquerader. Gastroenterol Hepatol. 2013 Apr;9(4):255-256. http://www.ncbi.nlm.nih.gov. Accessed 20 Jan 2015. PMID: PMC3977647
Jungst C, Berg T, Cheng J, et al. Intrahepatic cholestasis in common liver diseases. Eur J Clin Invest. 2013 Oct;43(10):1069-1083. doi: 10.1111/eci.12128. Accessed 20 Jan 2015. PMID: 23927644
Royal College of Obstetricians and Gynaecologists. Obstetric cholestasis. London (UK): RCOG Green-top Guideline. 2011;43. https://www.rcog.org.uk/globalassets/documents/guidelines/gtg_43.pdf. Accessed 12 Jan 2015
Rull G. Cholestasis. Patient.co.uk. http://www.patient.co.uk. Aug 2011. Accessed 17 Dec 2014.
Rull G. Obstetric cholestasis. Patient.co.uk. http://www.patient.co.uk. Aug 2011. Accessed 17 Dec 2014.
Tran TT, Ahn J, Reau NS. American College of Gastroenterology (ACG) clinical guideline: liver disease and pregnancy. Am J Gastroenterol. 2016 Feb;111(2):176-194. doi: 10.1038/ajg.2015.430. Accessed 24 Oct 2016. PMID: 26832651
Aabakken L, Karlsen TH, Albert J, et al. Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline. Endoscopy. 2017 Jun;49(6):588-608. doi: 10.1055/s-0043-107029. PMID: 28420030
European Association for the Study of the Liver. EASL clinical practice guidelines: The diagnosis and management of patients with primary biliary cholangitis. J Hepatol. 2017 Jul;67(1):145-172. doi: 10.1016/j.jhep.2017.03.022. Accessed 18 Feb 2019. PMID: 28427765
Lindor KD, Lee RH. Intrahepatic cholestasis of pregnancy. UpToDate. https://www.uptodate.com. 08 Dec 2020.

Product Highlight - Ravida

13 Sep 2022

Ravidasvir 200 mg tab

Reducing risks and improving long-term outcomes in patients with CHB

Prof. Vincent Wong, Prof. Ray Kim, Dr. Tan Poh Seng, 10 Sep 2019

Chronic hepatitis B (CHB) remains a major public health concern because of its worldwide distribution and potential adverse sequelae, including cirrhosis and hepatocellular carcinoma (HCC). At a recent symposium held during the GIHep Singapore 2019, Professor Vincent Wong from the Chinese University of Hong Kong and Professor Ray Kim from the Stanford University School of Medicine, Stanford, California, US, discussed antiviral treatments for CHB, with a focus on the novel agent tenofovir alafenamide (Vemlidy®). Dr Tan Poh Seng from the National University Hospital, Singapore, chaired the symposium.

Relationship between tumour response to systemic therapy and overall survival in unresectable hepatocellular carcinoma

Dr Raghav Sundar, 09 Sep 2019

Overall survival (OS) is currently the primary criteria in assessing the efficacy of a cancer treatment. Dr Raghav Sundar, a consultant medical oncologist at the National University Hospital, Singapore, details the crucial role played by tumour response in evaluating treatment efficacy, with a focus on the multiple kinase inhibitor lenvatinib in the treatment of hepatocellular carcinoma (HCC).